SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-047445
Filing Date
2024-11-13
Accepted
2024-11-13 09:02:37
Documents
92
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q xfor-20240930.htm   iXBRL 10-Q 1422434
2 EX-31.1 ex-311q32024.htm EX-31.1 9260
3 EX-31.2 ex-312q32024.htm EX-31.2 9248
4 EX-32.1 ex-321q32024.htm EX-32.1 5455
  Complete submission text file 0001628280-24-047445.txt   7474993

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xfor-20240930.xsd EX-101.SCH 60640
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xfor-20240930_cal.xml EX-101.CAL 71710
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xfor-20240930_def.xml EX-101.DEF 218136
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xfor-20240930_lab.xml EX-101.LAB 659662
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xfor-20240930_pre.xml EX-101.PRE 459683
94 EXTRACTED XBRL INSTANCE DOCUMENT xfor-20240930_htm.xml XML 1034593
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38295 | Film No.: 241451451
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)